|  |  | Choline (Cho) | Creatine (Cre) | Cho/Cre | |||
---|---|---|---|---|---|---|---|---|
 |  |  | Frontal | Temporal | Frontal | Temporal | Frontal | Temporal |
Healthy Controls | Age | Sex | Â | Â | Â | Â | Â | Â |
1 | 50 | M | 3.51 | 2.95 | 6.67 | 8.53 | 0.53 | 0.35 |
2 | 45 | M | 2.19 | 3.03 | 10.1 | 9.11 | 0.22 | 0.33 |
3 | 43 | F | 3.01 | 2.31 | 9.97 | 9.52 | 0.30 | 0.24 |
4 | 39 | M | 2.11 | 2.72 | 7.94 | 7.60 | 0.27 | 0.24 |
5 | 37 | F | 2.47 | 2.34 | 9.98 | 9.89 | 0.25 | 0.24 |
6 | 36 | F | 1.91 | 1.76 | 8.28 | 8.19 | 0.23 | 0.22 |
7 | 35 | M | 1.76 | 2.36 | 7.93 | 8.36 | 0.22 | 0.28 |
8 | 32 | F | 1.88 | 1.51 | 9.56 | 9.56 | 0.2 | 0.16 |
9 | 32 | M | 1.94 | 2.14 | 7.04 | 7.79 | 0.28 | 0.28 |
10 | 30 | F | 1.82 | 2.52 | 7.8 | 8.63 | 0.23 | 0.29 |
11 | 28 | M | 1.72 | 2.23 | 7.16 | 8.51 | 0.24 | 0.26 |
Mean | 37.00 | Â | 2.21 | 2.35 | 8.40 | 8.70 | 0.27 | 0.26 |
Valproate Treated Patients | Â | Â | Â | Â | Â | Â | ||
1 | 58 | F | 2.72 | 2.1 | 9.16 | 10.13 | 0.30 | 0.21 |
2 | 50 | M | 2.61 | 3.42 | 8.17 | 10.53 | 0.32 | 0.33 |
3 | 49 | F | 2.03 | 1.79 | 8.56 | 7.48 | 0.24 | 0.24 |
4 | 48 | F | 2.44 | 1.88 | 9.93 | 8.19 | 0.25 | 0.23 |
5 | 36 | M | 2.60 | 2.53 | 7.84 | 7.51 | 0.33 | 0.34 |
6 | 35 | F | 2.07 | 2.77 | 9.26 | 10.39 | 0.22 | 0.27 |
7 | 35 | F | 2.78 | 1.89 | 8.35 | 9.79 | 0.33 | 0.19 |
8 | 34 | F | 1.76 | 2.93 | 7.26 | 8.01 | 0.24 | 0.37 |
9 | 34 | F | 2.43 | 2.27 | 7.75 | 7.23 | 0.31 | 0.31 |
Mean | 42.11 | Â | 2.38 | 2.40 | 8.48 | 8.81 | 0.28 | 0.28 |